Long-Term Outcomes of Orthotopic Liver Transplantation in Human Immunodeficiency Virus–Infected Patients and Comparison With Human Immunodeficiency Virus–Negative Cases
✍ Scribed by U. Baccarani; G.L. Adani; F. Bragantini; A. Londero; C. Comuzzi; A. Rossetto; D. Lorenzin; V. Bresadola; A. Risaliti; F. Pea; P. Toniutto; A. Donini; D. De Anna; F. Bresadola; M. Tavio; P. Viale
- Book ID
- 113935005
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 124 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The outcome of patients with hepatitis B virus (HBV) and human immunodeficiency virus (HIV) referred for liver transplantation (LT) is unknown. A high frequency of lamivudine-resistant (LAM-R) HBV infection may increase the risk of liver-related death pre-transplantation and prophylaxis failure post
Spanish Foundation for the Investigation and Prevention of Acquired Immunodeficiency Syndrome/Spanish Group for the Study of Acquired Immunodeficiency Syndrome Prospective Cohort Study.'' 1 Surprisingly, in a cohort of 84 consecutive patients coinfected with human immunodeficiency virus (HIV) and he